Volume 16, Number 10—October 2010
Research
Effectiveness of Personal Protective Equipment and Oseltamivir Prophylaxis during Avian Influenza A (H7N7) Epidemic, the Netherlands, 2003
Dennis E. te Beest
, Michiel van Boven, Marian E.H. Bos, Arjan Stegeman, and Marion P.G. Koopmans
, Michiel van Boven, Marian E.H. Bos, Arjan Stegeman, and Marion P.G. KoopmansTable 7
Risk for infection with avian influenza A (H7N7) with different levels of oseltamivir use, on the basis of conjunctivitis as case definition, the Netherlands, 2003*
| Oseltamivir use | Risk† (95% CI) |
|---|---|
| Not used | 0.115 (0.064–0.180) |
| Not prescribed | 0.098 (0.040–0.189) |
| Prescribed but not used during visit |
0.127 (0.055–0.227) |
| Used | 0.054 (0.026–0.097) |
| Prescribed and used consistently | 0.041 (0.012–0.091) |
| Prescribed and used inconsistently | 0.052 (0.010–0.135) |
| Prescribed and consistency of use unknown |
0.149 (0.029–0.360) |
| Unknown | 0.073 (0.032–0.135) |
| Prescribed but period of use unknown | 0.073 (0.032–0.135) |
*CI, confidence interval.
†Probability of infection per visit.
